Clarion utilizes aeroponics to cultivate premium cannabis flower in a controlled, indoor environment. Between our proprietary algorithms that have been developed over the last six years, a proven track record of successfully scaling & operating in mature cannabis markets, and 30+ years of combined cannabis & pharmaceutical experience, Clarion is positioned to be a leader in the cultivation of premium cannabis flower for the European market. Clarion works with European-based distributors that are seeking a reliable source of indoor-grown, premium cannabis flower. We can supply cannabis flower either as a branded/finished product, or on a wholesale basis. Clarion is seeking distribution partners with a long-term outlook on the industry that want to grow with us as the industry matures. Clarion can tailor our batches to deliver whatever mix of unique genetics and batch sizes our distribution partners require. Our facility has been designed to facilitate small-batch orders without compromising quality. We know how important quality, consistency & reliability is to our distribution partners. Over the last 500+ batches produced in our partner facility in Washington State we have achieved a standard deviation of 0.7% from our targeted potency. During this same period, our yield has never crossed the 20 CFUs/g threshold, meaning our product does not require irradiation. This translates into our distribution partners being able to supply its clients with consistent, non-irradiated, terpene-rich, high potency cannabis flower on a reliable basis. Our goal is to provide a product that allows our partners to create trust with their buyers.